A group of physicians assembled Tuesday on behalf of the FDA to rule that St. Jude Medical’s new heart device appears safe and effective in stroke prevention, according to the Minneapolis Star Tribune ...
- Patent Foramen Ovale (PFO) Closure Devices Market size is expected to rise by 2026 owing to increasing prevalence, escalating preferences for minimally-invasive, safety, technically feasible ...
Abbott has launched its Amplatzer Tailsman PFO Occlosion System in Europe. The device is designed to treat people with a patent foramen ovale (PFO) who have had a stroke and are at risk of having ...
Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...
FLAGSTAFF, Ariz. and MIAMI. — W. L. Gore & Associates (Gore) today responded to initial results reported in St. Jude Medical, Inc.’s RESPECT clinical trial. The RESPECT study investigated whether ...
Abbott Laboratories ABT recently launched its Amplatzer Talisman PFO Occlusion System in Europe. The Talisman device aims to treat patent foramen ovale (PFO) patients who have had a stroke and are at ...
Abbott Laboratories ABT recently received FDA approval for its Amplatzer Talisman PFO Occlusion System to treat patent foramen ovale (PFO) patients at risk of recurrent ischemic stroke. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results